Please assess the completion status of the following clinical trial:

Trial Title: Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (18-80)~* who are admitted to the ICU for hematemesis, or coffee ground emesis~Exclusion Criteria:~1. Patients younger than 18 yrs old or older than 80 yrs~2. Patients who refuse to consent to be in our study~3. Pregnant patients~4. Prior use of prokinetics in the last 48 hours~5. History of cardiac arrhythmia~6. Allergy to erythromycin or metoclopromide~7. Patients with QT prolongation (query 7)~   -

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Erythromycin (Type: EXPERIMENTAL): Intravenous erythromycin infusion (dose: 250 mg) 30 min-60 min before procedure
- Metoclopromide (Type: EXPERIMENTAL): Intravenous metoclopromide infusion (dose: 10 mg) 30-60 minutes prior to endoscopy
- Control (Type: NO_INTERVENTION): no medications will be given prior to endoscopy

Based on this trial design, predict the completion outcome and termination type (if applicable).